|
Sign In to gain access to subscriptions and/or personal tools.
|
Alterations of the cytokine network in patients undergoing cardiopulmonary bypass
A Sablotzki
Department of Anaesthesiology and Intensive Care Medicine, Justus-Liebig-University, Giessen
M Dehne
Department of Anaesthesiology and Intensive Care Medicine, Justus-Liebig-University, Giessen
I Welters
Department of Anaesthesiology and Intensive Care Medicine, Justus-Liebig-University, Giessen
T Menges
Department of Anaesthesiology and Intensive Care Medicine, Justus-Liebig-University, Giessen
N Lehmann
Department of Anaesthesiology and Intensive Care Medicine, Justus-Liebig-University, Giessen
G Görlach
Department of Cardiovascular Surgery, Justus-Liebig-University, Giessen
C Osmer
Department of Anaesthesiology and Intensive Care Medicine, Justus-Liebig-University, Giessen
G Hempelmann
Department of Anaesthesiology and Intensive Care Medicine, Justus-Liebig-University, Giessen
Cardiovascular surgery using extracorporeal circulation causes a systemic inflammatory response which often results in severe organ dysfunction and increased postoperative mortality. Advances in knowledge about the interactions of cytokines involved in the response to cardiopulmonary bypass (CPB) may improve the outcome of patients undergoing cardiac surgery. The purpose of our study was to investigate the fluctuations in cytokine production, during and after CPB. In 24 patients undergoing elective coronary artery bypass grafting, plasma levels of interleukins IL-2, IL-6, IL-10 and IL-12, soluble IL-2-receptor (sIL-2R), and transforming growth factor-beta (TGF-ß) were measured at eight time points before, during and after CPB, using a standardized enzyme-linked immunosorbant assay technique. There was a significant increase in plasma levels of IL-10, IL-6 and TGF-ß after weaning off CPB. The IL-2 plasma levels decreased after the onset of CPB until 24 h postoperatively (p < 0.05). Concentrations of sIL-2R decreased 20 min after the start of CPB until the end of the operation (p < 0.05). In the postoperative course, sIL-2R levels increased, with peak values 48 h after the end of the surgical procedure. The IL-12 levels decreased after weaning off CPB (p < 0.05) until 6 h postoperatively. The results of our study demonstrate an intraoperative-predominant immunosuppression, followed by an early postoperative immunological activation, combined with a distinct acute phase response.
Perfusion, Vol. 12, No. 6,
393-403 (1997)
DOI: 10.1177/026765919701200608

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. Franke, W. Lante, E. Kurig, L. G. Zoller, C. Weinhold, and A. Markewitz
Is interferon gamma suppression after cardiac surgery caused by a decreased interleukin-12 synthesis?
Ann. Thorac. Surg.,
July 1, 2006;
82(1):
103 - 109.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Fujii, S. Suehiro, H. Kumano, T. Shibata, K. Hattori, H. Hirai, and T. Aoyama
Relationship between granulocyte elastase and C3a under protamine dosing in on-pump cardiac surgery
Eur. J. Cardiothorac. Surg.,
September 1, 2005;
28(3):
431 - 434.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. K. Peel, S. C. Stamou, M. K. C. Dullum, P. C. Hill, K. A. Jablonski, A. S. Bafi, S. W. Boyce, K. R. Petro, and P. J. Corso
Chronologic distribution of stroke after minimally invasive versus conventional coronary artery bypass
J. Am. Coll. Cardiol.,
March 3, 2004;
43(5):
752 - 756.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Shakhar and S. Ben-Eliyahu
Potential Prophylactic Measures Against Postoperative Immunosuppression: Could They Reduce Recurrence Rates in Oncological Patients?
Ann. Surg. Oncol.,
October 1, 2003;
10(8):
972 - 992.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Borgermann, I. Friedrich, S. Flohe, J. Spillner, M. Majetschak, O. Kuss, A. Sablotzki, T. Feldt, J. C. Reidemeister, and F. U. Schade
Tumor necrosis factor-{alpha} production in whole blood after cardiopulmonary bypass: Downregulation caused by circulating cytokine-inhibitory activities
J. Thorac. Cardiovasc. Surg.,
September 1, 2002;
124(3):
608 - 617.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Sablotzki, I. Friedrich, J. Muhling, M. G Dehne, J. Spillner, R. E Silber, and E. Czeslik
The systemic inflammatory response syndrome following cardiac surgery: different expression of proinflammatory cytokines and procalcitonin in patients with and without multiorgan dysfunctions
Perfusion,
March 1, 2002;
17(2):
103 - 109.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
H. A. Hennein
Inflammation After Cardiopulmonary Bypass: Therapy for the Postpump Syndrome
Seminars in Cardiothoracic and Vascular Anesthesia,
September 1, 2001;
5(3):
236 - 255.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
D.J. Brull, H.E. Montgomery, J. Sanders, S. Dhamrait, L. Luong, A. Rumley, G.D.O. Lowe, and S.E. Humphries
Interleukin-6 Gene -174G>C and -572G>C Promoter Polymorphisms Are Strong Predictors of Plasma Interleukin-6 Levels After Coronary Artery Bypass Surgery
Arterioscler. Thromb. Vasc. Biol.,
September 1, 2001;
21(9):
1458 - 1463.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A Sablotzki, J Muhling, M G Dehne, B Zickmann, R E Silber, and I Friedrich
Treatment of sepsis in cardiac surgery: role of immunoglobulins
Perfusion,
March 1, 2001;
16(2):
113 - 120.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
S. B. Horton, W. W. Butt, R. J. Mullaly, C. A. Thuys, E. B. O’Connor, K. Byron, A. D. Cochrane, C. P. Brizard, and T. R. Karl
IL-6 and IL-8 levels after cardiopulmonary bypass are not affected by surface coating
Ann. Thorac. Surg.,
November 1, 1999;
68(5):
1751 - 1755.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Liebold, C. Keyl, and D. E. Birnbaum
The heart produces but the lungs consume proinflammatory cytokines following cardiopulmonary bypass
Eur. J. Cardiothorac. Surg.,
March 1, 1999;
15(3):
340 - 345.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|